에 대한 최신 뉴스 Ventas (NYSE:VTR) 주식

Ventas

Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.

Ventas Inc

VETROPACK HLDF ST PRX A by Vetropack Holding SA

Vitrolife AB

VECTRON SYSTEMS AG NEW by Vectron Systems AG New

Vectron Systems AG

Vitro Biopharma, Inc

Viatris Inc

VIATRIS ORD

VECTOR INC TOKYO by Vector Inc.

Vitru Ltd

Wells Fargo analyst John Kilichowski assumes Ventas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTR#NYSE">VTR</a>) with a Overweight rating and raises Price Target to $71.

News

Price Target

Initiation

Analyst Ratings

Wells Fargo Assumes Ventas at Overweight, Raises Price Target to $71

Ventas's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTR#NYSE">VTR</a>) short percent of float has risen 25.59% since its last report. The company recently reported that it has 9.80 million shares sold short, which is 3.19% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.33 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Ventas Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727718313_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Ventas has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Ventas's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Ventas's peer group average for short interest as a percentage of float is 7.38%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Looking Into Ventas's Recent Short Interest

7 analysts have expressed a variety of opinions on Ventas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTR#NYSE">VTR</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $63.86, a high estimate of $71.00, and a low estimate of $56.00. This current average has increased by 10.93% from the previous average price target of $57.57. 
<img src="https://www.benzinga.com/files/images/story/2024/1726506024_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
A clear picture of Ventas's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Steve Sakwa</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$70.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Richard Anderson</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$71.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Steve Sakwa</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$64.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Michael Carroll</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$63.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Nicholas Yulico</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$59.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Richard Anderson</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$64.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Steve Sakwa</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$56.00</td>
<td>$53.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Ventas. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Ventas compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Ventas's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Ventas's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/VTR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Ventas analyst ratings.</a>
<h2>Get to Know Ventas Better</h2>
Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
<h3>Ventas's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Positive Revenue Trend: Examining Ventas's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 8.55% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Real Estate sector.
Net Margin: Ventas's net margin is impressive, surpassing industry averages. With a net margin of 1.61%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Ventas's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 0.2%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.08%, the company showcases effective utilization of assets.
Debt Management: With a below-average debt-to-equity ratio of 1.39, Ventas adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Verdict: Ventas In The Eyes Of 7 Experts

Evercore ISI Group analyst Steve Sakwa maintains Ventas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTR#NYSE">VTR</a>) with a Outperform and raises the price target from $64 to $70.

Evercore ISI Group Maintains Outperform on Ventas, Raises Price Target to $70

Real Estate

Ventas Enters Agreements With Kindred And ScionHealth Including Regarding 23 Long Term Acute Care Hospitals Whose Lease Term Is Scheduled To Mature On Apr. 30; Initial Annualized Cash Contractual Base Rent For The LTACS Will Be $80M Starting May 1, 2025, Consistent With The Company's Previously Announced Expectations, And Rent Will Escalate Annually By 2.75% Through The Extended Lease Maturity Date Of April 30, 2030

Ventas's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTR#NYSE">VTR</a>) short percent of float has fallen 3.41% since its last report. The company recently reported that it has 7.80 million shares sold short, which is 2.55% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.8 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Ventas Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1725973213_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Ventas has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Ventas's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Ventas's peer group average for short interest as a percentage of float is 3.71%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Wedbush analyst Richard Anderson maintains Ventas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTR#NYSE">VTR</a>) with a Outperform and raises the price target from $64 to $71.

Wedbush Maintains Outperform on Ventas, Raises Price Target to $71

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Ventas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTR#NYSE">VTR</a>) in the last three months.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $61.2, a high estimate of $64.00, and a low estimate of $56.00. This upward trend is apparent, with the current average reflecting a 11.27% increase from the previous average price target of $55.00.
<img src="https://www.benzinga.com/files/images/story/2024/1724871652_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The analysis of recent analyst actions sheds light on the perception of Ventas by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Steve Sakwa</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$64.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Michael Carroll</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$63.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Nicholas Yulico</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$59.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Richard Anderson</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$64.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Steve Sakwa</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$56.00</td>
<td>$53.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Ventas. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Ventas compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Ventas's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Ventas's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/VTR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Ventas analyst ratings.</a>
<h2>All You Need to Know About Ventas</h2>
Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
<h3>Ventas: A Financial Overview</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Ventas displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 8.55%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Real Estate sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 1.61%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Ventas's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 0.2%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.08%, the company showcases effective utilization of assets.
Debt Management: Ventas's debt-to-equity ratio is below the industry average. With a ratio of 1.39, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For Ventas's Future

Evercore ISI Group analyst Steve Sakwa maintains Ventas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTR#NYSE">VTR</a>) with a Outperform and raises the price target from $61 to $64.

Evercore ISI Group Maintains Outperform on Ventas, Raises Price Target to $64

Ventas's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTR#NYSE">VTR</a>) short percent of float has risen 3.12% since its last report. The company recently reported that it has 7.86 million shares sold short, which is 2.64% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.86 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Ventas Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1723233613_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Ventas has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Ventas's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Ventas's peer group average for short interest as a percentage of float is 6.91%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Ventas?

RBC Capital analyst Michael Carroll maintains Ventas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTR#NYSE">VTR</a>) with a Outperform and raises the price target from $52 to $63.

RBC Capital Maintains Outperform on Ventas, Raises Price Target to $63

Scotiabank analyst Nicholas Yulico maintains Ventas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTR#NYSE">VTR</a>) with a Sector Perform and raises the price target from $55 to $59.

Scotiabank Maintains Sector Perform on Ventas, Raises Price Target to $59

Wedbush analyst Richard Anderson maintains Ventas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTR#NYSE">VTR</a>) with a Outperform and raises the price target from $54 to $64.

Wedbush Maintains Outperform on Ventas, Raises Price Target to $64

As of Aug 5, 2024, two stocks in the real estate sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the<a href="https://www.benzinga.com/topic/rsi"> RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Ventas Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTR#NYSE">VTR</a>)</h3>
<ul>
<li>On Aug. 1, Ventas posted better-than-expected quarterly results. &#8220;We started 2024 with momentum, which continued in the second quarter as we delivered another quarter of strong results. We are executing on our focused strategy to capture the unprecedented multiyear growth opportunity in senior housing,&#8221; said Debra A. Cafaro, Ventas Chairman and CEO. The company's stock gained around 8% over the past month and has a <a href="https://www.benzinga.com/quote/VTR">52-week high of $57.16</a>.</li>
<li>RSI Value: 78.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>VTR Price Action: Shares of Ventas gained 0.3% to trade at $56.54 on Monday.</li>
</ul>
<h3 class="wp-block-heading">American Tower Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMT#NYSE">AMT</a>)</h3>
<ul>
<li>On July 30, American Tower reported better-than-expected second-quarter financial results. Steven Vondran, American Tower&#8217;s Chief Executive Officer, stated, &#8220;The momentum from the start of the year extended into Q2, with core results highlighting the strong underlying demand for our portfolio of communications assets. Positive collection trends further accelerated in India, our U.S. &amp; Canada segment delivered over 5% Organic Tenant Billings Growth and CoreSite achieved its second highest quarter of signed new business on record, all supporting over 13% Attributable AFFO per Share growth in the quarter, and our ability to raise the midpoints of the key financial measures in our updated 2024 outlook.&#8221; The company's stock gained around 18% over the past month and <a href="https://www.benzinga.com/quote/AMT">has a 52-week high </a>of $236.13.</li>
<li>RSI Value: 73.03</li>
<li>AMT Price Action: Shares of American Tower fell 2% to trade at $230.00 on Monday.</li>
</ul>
Read More:<a href="https://www.benzinga.com/news/24/08/40161976/home-depot-to-rally-more-than-14-here-are-10-top-analyst-forecasts-for-monday"> </a>
<ul>
<li><a href="https://www.benzinga.com/news/24/08/40161976/home-depot-to-rally-more-than-14-here-are-10-top-analyst-forecasts-for-monday">Home Depot To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Monday</a></li>
</ul>

Intraday Update

Markets

Top 2 Real Estate Stocks That May Dip In August

Ventas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTR#NYSE">VTR</a>) reported quarterly earnings of $0.80 per share which beat the analyst consensus estimate of $0.79 by 1.27 percent. The company reported quarterly sales of $1.20 billion which beat the analyst consensus estimate of $1.19 billion by 0.54 percent. This is a 8.59 percent increase over sales of $1.11 billion the same period last year.

Earnings

Earnings Beats

Ventas Q2 2024 FFO $0.80 Beats $0.79 Estimate, Sales $1.20B Beat $1.19B Estimate

Ventas's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTR#NYSE">VTR</a>) short percent of float has fallen 6.57% since its last report. The company recently reported that it has 7.61 million shares sold short, which is 2.56% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.92 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Ventas Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721240115_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Ventas has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Ventas's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Ventas's peer group average for short interest as a percentage of float is 6.48%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(VTR) - Analyzing Ventas's Short Interest

Evercore ISI Group analyst Steve Sakwa maintains Ventas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTR#NYSE">VTR</a>) with a Outperform and raises the price target from $53 to $56.

Evercore ISI Group Maintains Outperform on Ventas, Raises Price Target to $56

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2024/07/09/final-trades-nasdaq-energy-transfer-hilton-worldwide-and-ventas.html">Halftime Report Final Trades</a>,&#8221; Joshua Brown of Ritholtz Wealth Management said he <a href="https://www.benzinga.com/quote/NDAQ/earnings">likes Nasdaq, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>).</a>
Nasdaq will release earnings results for the second quarter on Thursday, July 25. Analysts expect the company to report quarterly earnings at 63 cents per share on revenue of $1.12 billion.
Bryn Talkington of Requisite Capital Management said Energy Transfer LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ET#NYSE">ET</a>) is one of the best pipeline plays in the business. The company's stock is up 17% year-to-date and has an 8% yield.
Energy Transfer expects to release earnings for the second quarter on Wednesday, Aug. 7, after the closing bell. The company is projected to post quarterly earnings at 35 cents share, up from 25 cents per share in the year-ago period.
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>.
Jenny Van Leeuwen Harrington of Gilman Hill Asset Management named Ventas, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTR#NYSE">VTR</a>) as her final trade.
On May 14, Ventas declared a second-quarter 2024 dividend of 45 cents per common share.
Joseph M. Terranova of Virtus Investment Partners picked Hilton Worldwide Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>).
On June 21, Susquehanna analyst Christopher Stathoulopoulos initiated coverage on Hilton Worldwide with a Neutral rating and announced a price target of $215.
Price Action:
<ul>
<li>Nasdaq shares gained 0.6% to close at $60.81 on Tuesday.</li>
<li>Energy Transfer rose 0.2% to settle at $16.12 during Tuesday's session.</li>
<li>Hilton Worldwide shares rose 0.3% to close at $215.25.</li>
<li>Ventas shares gained 0.7% to close at $52.24 during Tuesday's session.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39690602/delta-air-lines-likely-to-report-lower-q2-earnings-here-are-the-recent-forecast-changes-from-wall-s">Delta Air Lines Likely To Report Lower Q2 Earnings; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>

Long Ideas

Media

NDAQ

Nasdaq, Ventas, Hilton Worldwide And An Energy Stock: CNBC's 'Final Trades'

CNBC Halftime Report Final Trades: Nasdaq, Energy Transfer LP, Hilton Worldwide, Ventas

Shares of Ventas (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vtr#NYSE">VTR</a>) scaled a new 52-week high of $51.94 on Jul 3. Moreover, over the past three months, VTR has gained 20.3%, outperforming the industry.
This Chicago-based healthcare real estate investment trust (REIT) is witnessing an upward trend in its stock price due to favorable fundamentals. Rising healthcare spending and an aging population continue to aid Ventas&#39; senior housing operating portfolio. Also, the outpatient medical portfolio is expected to continue gaining from favorable outpatient visit trends.
In May, Ventas came up with a solid first-quarter 2024 performance. The results reflected better-than-anticipated revenues. The company&#39;s same-store cash net operating income (NOI) increased year over year on strong performance across the portfolio, except for triple-net leased properties.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/10/70353.jpg?v=176060041" />
Image Source: Zacks Investment Research
Let&#39;s delve deeper into what&#39;s driving the stock.
<h3>Key Growth Drivers</h3>
Favorable SHOP Dynamics: The senior citizen population is expected to rise in the years ahead. As a result, the national healthcare expenditure by senior citizens, who constitute a major customer base for healthcare services and incur higher healthcare expenditures than the average population, is likely to increase in the upcoming period.
With an expectation of a rising senior citizens population in the years ahead and muted new supply in its markets, VTR is well-prepared for a compelling multiyear growth opportunity.
The U.S. senior housing multiyear growth opportunity is driven by record demand and decelerating new supply. The company expects favorable supply-demand fundamentals, its well-invested properties and operators supported by its Ventas OI platform to drive growth. Our estimate indicates a year-over-year rise of 18.3% in the SHOP segment&#39;s NOI in 2024.
Growing OM Visit Trend: Amid favorable demographics and growing outpatient trends, Ventas is committed to capitalizing on this upside within its outpatient medical and research portfolio, which includes outpatient medical buildings and research centers.
The same-store NOI growth for this segment was more than 3% in 2022 and 2023. While we estimate a 1.3% year-over-year increase in 2024, the company&#39;s outpatient medical and research segment&#39;s NOI is expected to grow 4.7% in 2025.
Accretive Investments:&nbsp; Ventas is carrying out accretive investments to enhance its research portfolio, which is essential for the delivery of crucial healthcare services and research related to life-saving vaccines and therapeutics. The company owns research centers in life science clusters, with a presence in some of the top-tier research university campuses.
Balance Sheet &amp; Cash Flow Strength: Ventas maintains a healthy balance sheet position and takes appropriate measures to enhance its liquidity position and financial strength. As of Mar 31, 2024, its liquidity totaled $3.4 billion of liquidity. In addition, the company also enjoys credit ratings of BBB+ stable from S&amp;P Global Ratings and Baa1 stable from Moody&#39;s, rendering it access to the debt market at favorable costs. With enough financial flexibility, Ventas is well-positioned to capitalize on growth opportunities.
VTR&#39;s current cash flow growth is projected at 19.51% against the 5.32% decline estimated for the industry.
<h3>Stocks to Consider</h3>
Some better-ranked stocks from the broader REIT sector are Alexandria Real Estate Equities (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/are#NYSE">ARE</a>) and Americold Realty Trust (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cold#NYSE">COLD</a>), each carrying a Zacks Rank #2 (Buy) at present.
The Zacks Consensus Estimate for ARE&#39;s 2024 FFO per share stands at $9.49, indicating an increase of 5.8% from the year-ago reported figure.
The Zacks Consensus Estimate for COLD&#39;s 2024 FFO per share is pinned at $1.44, suggesting year-over-year growth of 13.4%.
Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.
<a href="https://www.zacks.com/stock/news/2297045/ventas-vtr-hits-52-week-high-will-the-stock-trend-higher?cid=CS-BENZ-FT-analyst_blog|52week_high/low-2297045">To read this article on Zacks.com click here.</a>

REIT

COLD

Ventas Hits 52-Week High: Will the Stock Trend Higher?

The Federal Reserve's larger-than-expected interest rate cut has Wall Street soaring higher Thursday.

Dow, SPX Score Record Highs On Heels Of Rate Cut

Fed Goes Big

Global Medical REIT's Underwriting Is Demonstrated To Be Effective

Guggenheim Risk Managed Real Estate Fund Q2 2024 Commentary

TCW Global Real Estate Fund Q2 2024 Commentary

Major real estate stocks see marginal losses, REITs continue to gain

Life science space supply far outstrips demand, fueling higher office vacancy rates

Lazard Real Assets Portfolio Q2 2024 Commentary

Ventas (VTR – Research Report) received a Buy rating and a $71.00 price target from Wells Fargo analyst James Feldman today. The company's shares c...

Ventas (VTR) was upgraded to a Buy Rating at Wells Fargo

Wells Fargo upgrades 3, downgrades 2 healthcare REITs on price to earnings growth and yield

AAPL

ACWI

BBRE

CBRE

CHCT

CSGP

CTRE

DFAR

EQIX

FREL

GMRE

INDS

INVH

JPRE

KBWY

LAMR

MORT

NETL

NURE

NVDA

NXRT

PECO

PLDGP

PPTY

REXR

ROOF

RSPR

SBAC

SBRA

SCHH

SEVN

SOHO

SPRE

SRVR

SSEZF

SSEZY

TMHC

TRGP

TSLA

USRT

VCISF

VCISY

VICI

VRAI

WELL

XLRE

Press Releases

Ventas Issues Business Update

Ventas to Present at Nareit's REITweek 2024 Investor Conference

Ventas Announces Second Quarter 2024 Earnings Release Date and Conference Call

Ventas Reports 2024 Second Quarter Results

Ventas Announces Pricing of Senior Notes Offering

Ventas to Participate in Investor Meetings at BofA Securities 2024 Global Real Estate Conference

Ventas Releases 2023-2024 Corporate Sustainability Report

Ventas Reaches Agreements with Kindred and ScionHealth

Ventas Declares Third Quarter 2024 Dividend of $0.45 Per Common Share

Ventas Announces Third Quarter 2024 Earnings Release Date and Conference Call

American Healthcare REIT, Inc. Common Stock

American Healthcares

Alexandria Real Estate Equities, Inc. Common Stock

Alexandria Real Estate

Community Healthcare Trust Incorporated Common Stock

Community Healthcare

CareTrust REIT

Diversified Healthcare Trust - Common Shares of Beneficial Interest

Diversified Healthcare

Healthpeak Properties

Global Medical REIT

Healthcare Realty Trust Incorporated Common Stock

Healthcare Realty Trust

LTC Properties

Medical Properties Trust, Inc. common stock

Medical Properties Trust

National Health Investors, Inc. Common Stock

National Health Investors

Omega Healthcare Investors, Inc. Common Stock

Omega Healthcare Invts

Sabra Health Care REIT, Inc. - Common Stock

Sabra Health Care REIT

Sila Realty Trust

Strawberry Fields REIT, Inc. Common Stock

Strawberry Fields REIT

Universal Health Realty Income Trust Common Stock

Comments

Ventas

뉴스

에 대한 최신 뉴스 Ventas (NYSE:VTR) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌